The Department of Health and Social Care (DHSC) has suggested Estradiol patch as an alternative for patients who use 1 pump of Oestrogel daily.
DHSC has updated Annex A of SSP022 and SSP023 for Oestrogel Pump-Pack 0.06 per cent gel to include a dose conversion to a specific alternative Estradiol patch. Previously, only dose conversions for patients using 2 to 4 pumps daily were included in Annex A of SSP022 and SSP023.
Separately, the supporting guidance for three SSPs which allow quantity restriction have been updated to reflect the requirement to endorse the reduced quantity supplied in accordance with these SSPs.
- SSP019 – Oestrogel pump-pack 0.06% gel
- SSP020 – Ovestin 1mg cream
- SSP021 – Premique low dose 0.3mg/1.5mg modified release tablets
“When endorsing an SSP for a reduced quantity, contractors must ensure that the correct SSP number is endorsed along with the product name and the reduced quantity supplied in accordance with the SSP,” said PSNC.
It added, “Pharmacists must check that they are using the current version of the SSP, particularly when referring to a hard copy version. Amendments may become necessary prior to the published expiry date. Current versions of SSP templates and supporting guidance for each SSP can be found on the dedicated page of the NHSBSA’s website.”
To assist pharmacists in selecting the correct SSP for HRT medicines, PSNC’s Dispensing & Supply team have created easy to use flow charts. These charts also remind contractors of the correct SSP endorsement requirements (with examples) and charge status to apply to the Electronic Reimbursement Endorsement Messages (EREMs) before SSP claims are submitted for payment to the NHSBSA. Click here for top tips and helpful reminders on correct SSP endorsement and submission requirements.
